Navigation Links
Ted Pacha Joins Pinnaclife as President of its Healthcare Distribution Division
Date:5/24/2012

CORALVILLE, Iowa, May 24, 2012 /PRNewswire/ -- McCord Research, the parent company of Pinnaclife, announced today that Ted Pacha has been named president of its healthcare distribution division. "We are very pleased to have Mr. Pacha join our growing company. He has years of healthcare distribution experience. His executive management skills will help our domestic and global operations," said Darlene McCord, Ph.D., the company's CEO.

(Photo: http://photos.prnewswire.com/prnh/20120524/CG13716)

(Logo: http://photos.prnewswire.com/prnh/20120510/CG05130LOGO)

Mr. Pacha is well known in Iowa City and around the United States for building one of the nations largest and most successful healthcare distribution companies. Hawkeye Medical grew from an idea to a company doing more than $75 million a year and employing better than 100 employees in Iowa City. His leadership as a business owner and a philanthropist has set the standard for all Iowa companies.

As owner of Hawkeye Medical, Mr. Pacha decided that the best way to grow his company in a world of industry giants was to work cooperatively with other distributors and to become part of a buying group. He not only participated in that group, that became National Distribution Company (NDC), he went on to serve for years as its Chairman of the Board. Today, NDC is that largest independent healthcare distribution company in the United States with sales exceeding 7-billion dollars.

Mr. Pacha will now build the business opportunity between Pinnaclife and NDC. The relationship is starting off with the launch of a line of pet care products that will be sold exclusively through veterinarians. The new line will be sold under the Pinnaclife brand and is endorsed by the two leading veterinary dermatologists. "The opport
'/>"/>

SOURCE McCord Research
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer
2. David F. Harty Joins Systech International as Vice President
3. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
4. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
5. Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
6. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
7. Veteran FCPA and White Collar Attorney Michael Volkov Joins LeClairRyan
8. Top Ranked Equity Analyst Joins Vital Therapies, Inc.
9. Tom Weller Joins Hyde Engineering and Consulting
10. EHE International Joins Forces With Entertainment Industry Foundations National Colorectal Cancer Research Alliance and the CDC to Encourage Screening
11. Wendy D. Lynch, Ph.D., Joins Angeions Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015  Asterias Biotherapeutics, Inc. (NYSE ... emerging field of regenerative medicine, today announced that ... Chicago -based Rush University Medical Center ... of escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) ... complete cervical spinal cord injury (SCI). This represents ...
(Date:8/31/2015)...   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue ... media and a related cloud hosted biologistics ... shippers ("BioLife" or the "Company"), today announced ... company focused on developing and commercializing novel therapeutics ...
(Date:8/28/2015)... JACKSONVILLE, Fla. , Aug. 28, 2015  With ... reaching deadlier heights, Jacksonville ... Philip Hemphill is helping to explain why ... Fentanyl is approximately 40 to 50 times more potent ... by recreational users as heroin, the risk of death ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2
(Date:8/31/2015)... ... ... it comes to undergoing a hair transplant, most patients have donor hair moved from one ... the hair on top of the scalp, as well as filling in areas missing hair, ... on other areas of their head. , What about patients who have a limited, or ...
(Date:8/31/2015)... ... August 31, 2015 , ... India ... new “ InstantQuote ” tool, which summarizes all available plans, plan maximums, pre-existing ... tool is designed to help India Network members make an informed decision regarding ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... The Lisle ... Firm Partner William Scott has been nominated by his peers to earn a “Leading ... than five percent of attorneys in the state of Illinois. The nomination process is ...
(Date:8/31/2015)... New York, NY (PRWEB) , ... August 31, ... ... on Malignant Mesothelioma is a one-day event geared to patients and family ... and presented by local and regional mesothelioma experts. The conference is a collaborative ...
(Date:8/31/2015)... ... August 31, 2015 , ... CareSource, ... and Corporate Communications. In this capacity, Michael will provide strategic leadership for CareSource’s ... leader in consumer-focused programs that have contributed to the company’s rapid growth. As ...
Breaking Medicine News(10 mins):Health News:Body Hair Transplants to Help Achieve a Full Head of Hair 2Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:CareSource Names Vice President, Marketing and Corporate Communications 2
... first of its kind, designed to measure the safety ... deficit/hyperactivity disorder// (ADHD) with methylphenidate (Ritalin), has revealed that ... cause harm. The study also revealed that it is ... sensitive than older children to the side effects of ...
... explained the recent improvements in the treatment of amyotrophic lateral ... paralysis. It is observed that people with the disease die ... actually stop working. Despite all the claims, cure for ALS ... disease. ,During the study, human fetal stem cells ...
... crumbling under the mounting pressure of dengue. Safdarjung Hospital ... patients being referred to AIIMS and the Red Cross. ... are given platelets only on the condition of their ... for the required platelets. Dr Santosh at the Dengue ...
... has confirmed that herceptin, a drug used for treating ... criticism// over the decision. The deputy medical director of ... expensive and funding could not be justified. The recommendation ... arrived at after complete investigation of the evidence. ...
... some valuable information which would definitely help us to ... an autistic person is blue printed. ,One ... by autism a developmental disorder typically characterized by exhibiting ... ,Lead researcher Dr Michael Murias, from the University of ...
... closet, as a virulent breast cancer strain that can be ... Among the many types of breast cancer, HER2, an aggressive ... 5 women. , ,HER2, which represents the human epidermal ... particular gene that takes care of cell growth, division and ...
Cached Medicine News:Health News:Reduced Doses of Medication Beneficial to Preschoolers with ADHD 2Health News:Reduced Doses of Medication Beneficial to Preschoolers with ADHD 3Health News:Mounting Pressure of Dengue in Delhi Hospitals 2
... use with the Moto Alpha unit, these new pads ... in which several successive runs may be sealed with ... to prevent a microplate from sticking to the block ... level of sealing performance, which means you can use ...
... Designed for use with the Moto Alpha unit, these ... cycle sequencing, in which several successive runs may be ... Alpha unit is engineered to prevent a microplate from ... pads provide an improved level of sealing performance, which ...
Microseal 'M' mats, seals 96-well plates, reusable, pkg of 10...
Omniseal TD mat. Reusable rubber mat for sealing PCR plates. 5 pk....
Medicine Products: